Wyeth Premarin low-dose
Executive Summary
Wyeth's low-dose Premarin (.45 mg estrogens) approved by FDA April 25. Estrogen level is 28% lower than standard .625 mg. FDA action comes one month after approval of low-dose Prempro (.45 mg estrogens/1.5 mg medroxyprogesterone) ("The Pink Sheet" March 17, p. 4). Both hormone therapies will launch this summer...